Mesna is used to reduce the risk of hemorrhagic cystitis (a condition that causes inflammation of the bladder and can result in serious bleeding) in people who receive ifosfamide (a medication used for the treatment of cancer). Mesna is in a class of medications called cytoprotectants. It works by protecting the bladder against some of the harmful effects of certain chemotherapy medications.
Mesna comes as a tablet to take by mouth. The first dose of mesna is usually given as an injection into your vein at the same time as you receive your chemotherapy treatment. After that, your doctor may choose to continue your treatment with mesna tablets. It is usually given 2 and 6 hours after your chemotherapy treatment. Take mesna exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
If you vomit less than 2 hours after you take a dose of mesna tablets, call your doctor right away.
Drink at least 1 quart (4 cups; about 1 liter) of liquid daily while you are taking mesna tablets.
Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.
Mesna may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
Prescribed | Used therapeutically to reduce the incidence of haemorrhagic cystitis and haematuria when a patient receives ifosfamide or cyclophosphamide for can... |
Weight : | 164.17 |
Structure | Mesna |
Formula | C2H5NaO3S2 |
Mesna (200 mg) | Mesna (200 mg) (Cipla) |
Mesna (200 mg) (Cytomed) | Mesna Inj (200 mg) |
Mistabron (300 mg) | Uromes (100 mg) |
Uromitexan (200 mg) | Urosna (100 mg) |